±èÂù
¼Ò
¼Ó
: ºÐ´çÂ÷º´¿ø
Àü¹®ºÐ¾ß : ´ëÀå¾Ï, ºñ´¢±â¾Ï(½ÅÀå¾Ï, ¹æ±¤¾Ï)
Á÷
ˤ
: ºÎ±³¼ö
¸Þ
ÀÏ
:
ºñ°ø°³
Àü
È
:
1577-4488
ÆÑ
½º
:
ÁÖ
¼Ò
:
°æ±âµµ ¼º³²½Ã ºÐ´ç±¸ ¾ßžµ¿ 351¹øÁö
ȨÆäÀÌÁö:
ÅǸ޴º
ÁÖ¿ä¹ßÇ¥³í¹®
¹øÈ£
±¸ºÐ
Á¦¸ñ
´Ù¿î·Îµå
22
ÇØ¿Ü
Rho GTPase RhoJ is associated with gastric cancer progression and metastasis. J Cancer 2016 (IF 3.609)
21
ÇØ¿Ü
Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients. BMC Cancer 2016 (IF 3.265)
20
ÇØ¿Ü
Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers. Brit J Cancer 2016 (IF 4.84)
19
ÇØ¿Ü
Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia. Annals of Surgery 2016 (IF 8.327)
18
ÇØ¿Ü
Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy. Oncology 2016 (IF 2.422)
17
ÇØ¿Ü
Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites. Oncotarget 2016 (IF 6.359)
16
ÇØ¿Ü
Methylation-dependent Regulation of HIF-1¥á Stability Restricts Retinal and Tumour Angiogenesis. Nature Communications 2016 (IF 11.470)
15
ÇØ¿Ü
The Clinicopathological Features and Prognostic Impact of ALK-positivity in Resected Gastric Cancer Patients. Annals of Surgical Oncology 2015 (IF 3.943)
14
ÇØ¿Ü
Novel Glycosylated VEGF Decoy Receptor, VEGF-Grab, Effectively Suppresses Tumor Angiogenesis and Progression. Molecular Cancer Therapeutics 2015 (IF 6.107)
13
ÇØ¿Ü
SIRT2 regulates tumour hypoxia response by promoting HIF-1¥á hydroxylation. Oncogene 2015 (IF 8.559)
1
2
3
4
5
Copyright ¨Ï chamc, All rights reserved.
ºü¸£°í Æí¸®ÇÑ ÀÎÅÍ³Ý Áø·á¿¹¾à
Àüȹ®ÀÇ
°³²Â÷º´¿ø 02.3468.3000
ºÐ´çÂ÷º´¿ø 031.780.5000
Â÷¿ò 02.3015.5300
±¸¹ÌÂ÷º´¿ø 054.450.9700
´ë±¸¿©¼ºÂ÷º´¿ø 02.222.4200
°³²°ÇÁø¼¾ÅÍ 02.2191.3900
ºÐ´çÁ¾ÇÕ°Ç°ÁõÁø¼¾ÅÍ 031.780.5940
½ºÆ÷·º½º °ÇÁø¼¾ÅÍ 02.3473.2111
±¸¹ÌÂ÷º´¿ø°ÇÁø¼¾ÅÍ 054.450.9800
ȨÆäÀÌÁö°ü¸®ÀÚ 031.780.1729